Table 1 Baseline data
No revision | Partial revision | Complete revision | |
|---|---|---|---|
N (22) | 16 | 2 | 4 |
Age [year] | 52.5 (SD 14) | 65.5 (SD 37) | 57.5 (SD 12) |
Gender [f:m] | 3:13 | 0.2 | 2.2 |
Indication | |||
Trauma | 9 | 2 | 1 |
Infection | 4 | 0 | 2 |
Cancer | 3 | 0 | 0 |
POVD | 0 | 0 | 1 |
Hospitalization after surgery (d) | 12 (SD 6.6) | 11.5 (SD 2.1) | 30 (SD 14.5; p = 0.0013) |
Comorbidities [n (%)] | |||
Diabetes | 2 (12.5%) | 0 | 3 (75%) |
POVD | 2 (12.5%) | 1 (50%) | 1 (25%) |
CHD | 2 (12.5%) | 0 | 1 (25%) |
Arterial hypertonia | 6 (37.5%) | 0 | 3 (75%) |
Atrial fibrillation | 0 | 0 | 1 (25%) |
Smoking | 3 (18.8%) | 0 | 1 (25%) |
Cancer history | 3 (18.8%) | 0 | 0 |
Oral anticoagulation | 1 (6.3%) | 0 | 1 (25%) |